Haymaker Acquisition Corp. II does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the consumer or consumer-related products and service industries. The company was founded in 2019 and is based in New York, New York.
On 12/13/2021 the company announced a proposed merger with BioTE Holdings, LLC, (Biote), a high-growth, differentiated medical practice-building business within the hormone optimization space.
$9.72 -0.28 (-2.80%)
As of 05/23/2022 14:29:20 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.